August 20, 2015 – On August 19, 2015, Lifehealth, LLC (“Lifehealth”) filed a complaint against Epocal Inc. (“Epocal”) asserting infringement of U.S. Patent Nos. 5,770,158 (“the ’158 Patent”) and 5,781,024 (“the ’024 Patent”) in the United States District Court for the Western District of Wisconsin. Lifehealth asserts that it is the owner by assignment of all rights and interests related to both asserted patents. The ’158 Patent is titled “Capillary Syringe” and is directed to a disposable, vented capillary draw device capable of dispending fluid. The ’025 Patent is titled “Instrument Performance Verification System” and is directed to a device and method for testing and monitoring the performance of various components electrically linked to a diagnostic instrument. Lifehealth asserts that Epocal is infringing the asserted patents by making, using, importing, selling and/or offering for sale a set of devices referred to as the EPOC® Blood Analysis System as well as capillary syringes known as Care-Full Capillary Tubes. The case remains pending and is docketed as Case No. 3:15-cv-00521 before Judge William M. Conley and Magistrate Judge Stephen L. Crocker.
By: Ketan V. Patel